Cargando…

Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification

PURPOSE: To compare the efficacy of a once-daily dose of 0.3% nepafenac and three times daily dose of 0.1% nepafenac in controlling pain and inflammation following phacoemulsification. METHODS: In this prospective randomized control single-blind study. patients who underwent uneventful phacoemulsifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bardoloi, Narayan, Sarkar, Sandip, Burgute, Pankaj Suresh, Deb, Amit Kumar, Dholkawala, Roshni, Aggarwal, Priyal, Gokhale, Tanmay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114608/ https://www.ncbi.nlm.nih.gov/pubmed/35225519 http://dx.doi.org/10.4103/ijo.IJO_2401_21

Ejemplares similares

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
por: Toyos, Melissa M.
Publicado: (2019)

Comparison between 0.1% Nepafenac and 1% Prednisolone Eye Drop in Postoperative Management Following Micro-incisional Cataract Surgery
por: Sarkar, Sandip, et al.
Publicado: (2021)

Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery
por: Nardi, M, et al.
Publicado: (2007)

Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema
por: Giarmoukakis, Athanassios K, et al.
Publicado: (2020)

Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy
por: Nagpal, Manish, et al.
Publicado: (2014)

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
por: Hariprasad, Seenu M, et al.
Publicado: (2009)

Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo
por: McCafferty, Sean, et al.
Publicado: (2017)

Evaluation effectiveness of 0.1% nepafenac on injection-related pain in patients undergoing intravitreal Ozurdex injection
por: Ogurel, Tevfik, et al.
Publicado: (2019)

In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits
por: Sheppard, John D., et al.
Publicado: (2018)

Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose
por: Silverstein, Steven M.
Publicado: (2019)

Ophthalmic nepafenac use in the Netherlands and Denmark
por: Margulis, Andrea V, et al.
Publicado: (2017)

Comparison of the efficacy of Diclofenac 0.1% and Nepafenac 0.1% on anterior chamber cells in patients undergoing cataract surgery: A prospective clinical practice trial
por: Ahmad, Adnan, et al.
Publicado: (2023)

Efficacy of Nepafenac versus Flurbiprofen in Maintaining Intraoperative Mydriasis During Phacoemulsification: A Comparative Study
por: Shrivastava, Ankur K, et al.
Publicado: (2021)

Comparison of preoperative nepafenac (0.1%) and flurbiprofen (0.03%) eye drops in maintaining mydriasis during small incision cataract surgery in patients with senile cataract: A randomized, double-blind study
por: Sarkar, Saumya, et al.
Publicado: (2015)

Topical nepafenac in the treatment of diabetic macular edema
por: Callanan, David, et al.
Publicado: (2008)

Eyelid excoriation and erythema with nepafenac eye drop
por: Saurabh, Kumar, et al.
Publicado: (2016)

Topical Nepafenac in Treatment of Acute Central Serous Chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2013)

Capsular tension ring assisted phacoemulsification of morgagnian cataract
por: Bardoloi, Narayan, et al.
Publicado: (2021)

Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
por: Singh, Rishi P, et al.
Publicado: (2017)

Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients
por: Numaga, Jiro
Publicado: (2011)

A Case of Allergic Urticaria After Ophthalmic Nepafenac Use
por: Yaşar, Erdoğan, et al.
Publicado: (2018)

Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
por: Aaronson, Alexander, et al.
Publicado: (2020)

Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site
por: Cable, Melissa
Publicado: (2012)

Phacoemulsification without hydroprocedure: A novel technique to deal with posterior polar cataracts
por: Bardoloi, Narayan, et al.
Publicado: (2022)

Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac
por: Cervantes-Coste, Guadalupe, et al.
Publicado: (2009)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
por: Gaynes, Bruce I, et al.
Publicado: (2008)

Zero Phaco: A new technique for dealing with soft cataracts
por: Bardoloi, Narayan, et al.
Publicado: (2022)

Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac
por: Sengupta, Sabyasachi, et al.
Publicado: (2018)

Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
por: Singh, Rishi, et al.
Publicado: (2012)

Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients
por: Abu Hussein, Nahla B., et al.
Publicado: (2017)

Nepafenac-Loaded Cyclodextrin/Polymer Nanoaggregates: A New Approach to Eye Drop Formulation
por: Lorenzo-Veiga, Blanca, et al.
Publicado: (2019)

In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation
por: Lorenzo-Veiga, Blanca, et al.
Publicado: (2020)

Comparison of macular thickness by optical coherence tomography measurements after uneventful phacoemulsification using ketorolac tromethamine, nepafenac, vs a control group, preoperatively and postoperatively
por: Stock, Ricardo Alexandre, et al.
Publicado: (2018)

Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications
por: Husmann, Rachel, et al.
Publicado: (2020)

Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
por: Yüksel, Bora, et al.
Publicado: (2017)

Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery
por: Tripathi, Amruta S
Publicado: (2022)

Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy
por: Sarfraz, Muhammad Haroon, et al.
Publicado: (2017)

Use of nepafenac (Nevanac(®)) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections
por: Chen, Eric, et al.
Publicado: (2010)

Effects of Topical Nepafenac and Fluorometholone on Macular Thickness After Posterior Capsulotomy Using Neodymium-doped Yttrium-Aluminum-Garnet Laser
por: Atilgan, Cemile Ucgul, et al.
Publicado: (2020)

Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
por: Tan, Qi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sm6ab34ijr1qv2g73banevtmqs